176 related articles for article (PubMed ID: 26094604)
1. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.
Galoian K; Qureshi A; D'Ippolito G; Schiller PC; Molinari M; Johnstone AL; Brothers SP; Paz AC; Temple HT
Int J Oncol; 2015 Aug; 47(2):465-72. PubMed ID: 26094604
[TBL] [Abstract][Full Text] [Related]
2. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.
Galoian KA; Guettouche T; Issac B; Qureshi A; Temple HT
Tumour Biol; 2014 Mar; 35(3):2335-41. PubMed ID: 24178909
[TBL] [Abstract][Full Text] [Related]
3. Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.
Galoian K; Abrahamyan S; Chailyan G; Qureshi A; Patel P; Metser G; Moran A; Sahakyan I; Tumasyan N; Lee A; Davtyan T; Chailyan S; Galoyan A
Int J Oncol; 2018 Jan; 52(1):139-154. PubMed ID: 29138803
[TBL] [Abstract][Full Text] [Related]
4. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
[TBL] [Abstract][Full Text] [Related]
5. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
[TBL] [Abstract][Full Text] [Related]
6. Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.
Galoian K; Scully S; Galoyan A
Neurochem Res; 2009 Feb; 34(2):379-85. PubMed ID: 18612811
[TBL] [Abstract][Full Text] [Related]
7. Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells.
Galoian K; Qureshi A; Wideroff G; Temple HT
Mol Clin Oncol; 2015 Jan; 3(1):171-178. PubMed ID: 25469290
[TBL] [Abstract][Full Text] [Related]
8. Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
Bao X; Ren T; Huang Y; Wang S; Zhang F; Liu K; Zheng B; Guo W
J Exp Clin Cancer Res; 2016 Aug; 35(1):129. PubMed ID: 27576314
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1.
Granger CJ; Hoyt AK; Moran A; Becker B; Sedani A; Saigh S; Conway SA; Brown J; Galoian K
Mol Med Rep; 2020 Nov; 22(5):3747-3758. PubMed ID: 32901865
[TBL] [Abstract][Full Text] [Related]
10. Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma.
Galoian K; Scully S; McNamara G; Flynn P; Galoyan A
Neurochem Res; 2009 Dec; 34(12):2117-21. PubMed ID: 19484491
[TBL] [Abstract][Full Text] [Related]
11. Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma.
Galoian K; Temple TH; Galoyan A
Neurochem Res; 2011 May; 36(5):812-8. PubMed ID: 21243426
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
Zhu Z; Wang CP; Zhang YF; Nie L
Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
[TBL] [Abstract][Full Text] [Related]
13. The overexpression of miR-30a affects cell proliferation of chondrosarcoma via targeting Runx2.
Jiang D; Zheng X; Shan W; Shan Y
Tumour Biol; 2016 May; 37(5):5933-40. PubMed ID: 26596830
[TBL] [Abstract][Full Text] [Related]
14. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
[TBL] [Abstract][Full Text] [Related]
15. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH
Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma.
Galoian K; Luo S; Qureshi A; Patel P; Price R; Morse AS; Chailyan G; Abrahamyan S; Temple HT
Mol Clin Oncol; 2016 Nov; 5(5):618-624. PubMed ID: 27900099
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression.
Tsai CH; Yang DY; Lin CY; Chen TM; Tang CH; Huang YL
Mol Oncol; 2017 Oct; 11(10):1380-1398. PubMed ID: 28672103
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
19. Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.
Galoian KA; Temple TH; Galoyan A
Tumour Biol; 2011 Aug; 32(4):745-51. PubMed ID: 21494810
[TBL] [Abstract][Full Text] [Related]
20. Analysis of microRNAs expressions in chondrosarcoma.
Yoshitaka T; Kawai A; Miyaki S; Numoto K; Kikuta K; Ozaki T; Lotz M; Asahara H
J Orthop Res; 2013 Dec; 31(12):1992-8. PubMed ID: 23940002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
